DODD DAVID A 4

What Happened

• David A. Dodd, President, CEO and Director of GeoVax Labs, Inc. (GOVX), received a grant/award of derivative securities representing 29,300 shares on 2026-06-17. The filing reports an acquisition price of $0.00 (no cash paid at grant) and a reported immediate value of $0 on the Form 4. This is an award of derivative securities (stock option/award), not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-06-17; Form 4 filed: 2026-06-22 (filed 5 days after the transaction).
• Reported terms: 29,300 shares @ $0.00 (derivative award; no cash exchanged at grant).
• Vesting/Exercise note (from filing): the award becomes exercisable in three equal annual installments on the first three anniversaries of the grant.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Filing timeliness: The Form 4 was filed after the transaction date (appears late under Section 16 two‑business‑day reporting rules), which can delay public transparency.

Context

• This was an equity award/option grant (a common form of executive compensation). Because it’s a derivative award with staged vesting, it does not represent an immediate market purchase or sale and does not necessarily indicate a near‑term change in trading behavior. The reported $0.00 acquisition price means no cash was paid at grant; potential value to the insider depends on future vesting and any exercise price and market performance.